https://clinicaltrials.gov/ct2/show/NCT03580278?type=Intr&cond=Psoriasis&lupd_s=04%2F04%2F2019&lupd_d=14
Condition : Psoriasis
Intervention : Biological: ABY-035/AFO2
Sponsor : Affibody
Not yet recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2
NCT03580278
Mon, 09 Jul 2018 12:00:00 EDT
Last Update Posted: 04/18/19 08:23AM
